Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience. (March 2022) - Cui, Wanyuan; Brown, Nick; Brown, Victoria; Bulusu, Ramesh; Denton, Arshi; Evans, Joanne; Forster, Martin; Papadatos-Pastos, Dionysis; Pellegrino, Loredana; Walsh, Nessa; Bruns, Rolf; Otto, Gordon; et al.